Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th April 2019)
- Record Type:
- Journal Article
- Title:
- Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th April 2019)
- Main Title:
- Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
- Authors:
- Elhai, Muriel
Boubaya, Marouane
Distler, Oliver
Smith, Vanessa
Matucci-Cerinic, Marco
Alegre Sancho, Juan José
Truchetet, Marie-Elise
Braun-Moscovici, Yolanda
Iannone, Florenzo
Novikov, Pavel I
Lescoat, Alain
Siegert, Elise
Castellví, Ivan
Airó, Paolo
Vettori, Serena
De Langhe, Ellen
Hachulla, Eric
Erler, Anne
Ananieva, Lidia
Krusche, Martin
López-Longo, F J
Distler, Jörg H W
Hunzelmann, Nicolas
Hoffmann-Vold, Anna-Maria
Riccieri, Valeria
Hsu, Vivien M
Pozzi, Maria R
Ancuta, Codrina
Rosato, Edoardo
Mihai, Carina
Kuwana, Masataka
Saketkoo, Lesley Ann
Chizzolini, Carlo
Hesselstrand, Roger
Ullman, Susanne
Yavuz, Sule
Rednic, Simona
Caimmi, Cristian
Bloch-Queyrat, Coralie
Allanore, Yannick
… (more) - Other Names:
- author non-byline.
Guiducci Serena author non-byline.
Walker Ulrich A author non-byline.
Kyburz Diego author non-byline.
Lapadula Giovanni author non-byline.
Maurer Britta author non-byline.
Jordan Suzana author non-byline.
Dobrota Rucsandra author non-byline.
Becvar Radim author non-byline.
Sierakowsky Stanislaw author non-byline.
Bielecka Otylia Kowal author non-byline.
Sulli Alberto author non-byline.
Cutolo Maurizio author non-byline.
Cuomo Giovanna author non-byline.
Nicoara Ileana author non-byline.
Kahan André author non-byline.
Vlachoyiannopoulos Panayiotis G author non-byline.
Montecucco Carlo Maurizio author non-byline.
Caporali Roberto author non-byline.
Stork Jiri author non-byline.
Inanc Murat author non-byline.
Carreira Patricia E author non-byline.
Novak Srdan author non-byline.
Czirják László author non-byline.
Varju Cecilia author non-byline.
Kucharz Eugene J author non-byline.
Kotulska Anna author non-byline.
Kopec-Medrek Magdalena author non-byline.
Widuchowska Malgorzata author non-byline.
Cozzi Franco author non-byline.
Rozman Blaz author non-byline.
Mallia Carmel author non-byline.
Coleiro Bernard author non-byline.
Gabrielli Armando author non-byline.
Farge Dominique author non-byline.
Wu Chen author non-byline.
Marjanovic Zora author non-byline.
Faivre Helene author non-byline.
Hij Darin author non-byline.
Dhamadi Roza author non-byline.
Wollheim Frank author non-byline.
Scheja Agneta author non-byline.
Wuttge Dirk M author non-byline.
Andréasson Kristofer author non-byline.
Martinovic Duska author non-byline.
Balbir-Gurman Alexandra author non-byline.
Trotta F author non-byline.
Monaco Andrea Lo author non-byline.
Pellerito Raffaele author non-byline.
Mauriziano Ospedale author non-byline.
Caramaschi Paola author non-byline.
Morovic-Vergles Jadranka author non-byline.
Black Carol author non-byline.
Denton Christopher author non-byline.
Damjanov Nemanja author non-byline.
Henes Jörg author non-byline.
Santamaria Vera Ortiz author non-byline.
Heitmann Stefan author non-byline.
Krasowska Matthias Dorota author non-byline.
Hasler Paul author non-byline.
Burkhardt Harald author non-byline.
Himsel Andrea author non-byline.
Bajocchi Gianluigi author non-byline.
Pereira Da Silva José Antonio author non-byline.
Salvador Maria João author non-byline.
Stamenkovic Bojana author non-byline.
Stankovic Aleksandra author non-byline.
Selmi Carlo Francesco author non-byline.
Santis Maria De author non-byline.
Tikly Mohammed author non-byline.
Denisov Lev N author non-byline.
Müller-Ladner Ulf author non-byline.
Frerix Marc author non-byline.
Tarner Ingo author non-byline.
Scorza Raffaella author non-byline.
Puppo Francesco author non-byline.
Engelhart Merete author non-byline.
Strauss Gitte author non-byline.
Nielsen Henrik author non-byline.
Damgaard Kirsten author non-byline.
Szücs Gabriela author non-byline.
Mendoza Antonio Zea author non-byline.
Puente Carlos de la author non-byline.
Sifuentes Giraldo WA author non-byline.
Midtvedt Øyvind author non-byline.
Reiseter Silje author non-byline.
Garen Torhild author non-byline.
Launay David author non-byline.
Valesini Guido author non-byline.
Ionescu Ruxandra Maria author non-byline.
Groseanu Laura author non-byline.
Opris Daniela author non-byline.
Cornateanu Roxana Sfrent author non-byline.
Ionitescu Razvan author non-byline.
Gherghe Ana Maria author non-byline.
Soare Alina author non-byline.
Gorga Marilena author non-byline.
Bojinca Mihai author non-byline.
Milicescu Mihaela author non-byline.
Sunderkötter Cord author non-byline.
Kuhn Annegret author non-byline.
Sandorfi Nora author non-byline.
Schett Georg author non-byline.
Beyer Christian author non-byline.
Meroni Pierluigi author non-byline.
Ingegnoli Francesca author non-byline.
Mouthon Luc author non-byline.
Keyser Filip De author non-byline.
Melsens Karin author non-byline.
Cantatore Francesco P author non-byline.
Corrado Ada author non-byline.
Iversen Line author non-byline.
Mühlen Carlos Alberto von author non-byline.
Bohn Jussara Marilu author non-byline.
Lonzetti Lilian Scussel author non-byline.
Eyerich Kilian author non-byline.
Hein Rüdiger author non-byline.
Knott Elisabeth author non-byline.
Wiland Piotr author non-byline.
Szmyrka-Kaczmarek Magdalena author non-byline.
Sokolik Renata author non-byline.
Morgiel Ewa author non-byline.
Madej Marta author non-byline.
Houssiau Frédéric A author non-byline.
Krummel-Lorenz Brigitte author non-byline.
Saar Petra author non-byline.
Aringer Martin author non-byline.
Günther Claudia author non-byline.
Westhovens Rene author non-byline.
Lenaerts Jan author non-byline.
Anic Branimir author non-byline.
Baresic Marko author non-byline.
Mayer Miroslav author non-byline.
Üprus Maria author non-byline.
Otsa Kati author non-byline.
Granel Brigitte author non-byline.
Müller Carolina de Souza author non-byline.
Radominski Sebastião C author non-byline.
Azevedo Valderílio F author non-byline.
Jimenez Sergio author non-byline.
Busquets Joanna author non-byline.
Agachi Svetlana author non-byline.
Groppa Liliana author non-byline.
Chiaburu Lealea author non-byline.
Russu Eugen author non-byline.
Popa Sergei author non-byline.
Zenone Thierry author non-byline.
Pileckyte Margarita author non-byline.
Mathieu Alessandro author non-byline.
Vacca Alessandra author non-byline.
Sampaio-Barros Percival D author non-byline.
Yoshinari Natalino H author non-byline.
Marangoni Roberta G author non-byline.
Martin Patrícia author non-byline.
Fuocco Luiza author non-byline.
Stebbings Simon author non-byline.
Highton John author non-byline.
Chapman Peter author non-byline.
O'Donnell John author non-byline.
Stamp Lisa author non-byline.
Doube Alan author non-byline.
Solanki Kamal author non-byline.
Veale Douglas author non-byline.
O'Rourke Marie author non-byline.
Loyo Esthela author non-byline.
Li Mengtao author non-byline.
Abdel Atty Mohamed Walid Ahmed author non-byline.
Amoroso Antonio author non-byline.
Gigante Antonietta author non-byline.
Oksel Fahrettin author non-byline.
Yargucu Figen author non-byline.
Tanaseanu Cristina-Mihaela author non-byline.
Popescu Monica author non-byline.
Dumitrascu Alina author non-byline.
Tiglea Isabela author non-byline.
Foti Rosario author non-byline.
Chirieac Rodica author non-byline.
Furst Daniel author non-byline.
Villiger Peter author non-byline.
Adler Sabine author non-byline.
Laar Jacob van author non-byline.
Kayser Cristiane author non-byline.
Fathi Nihal author non-byline.
Hassanien Manal author non-byline.
de la Peña Lefebvre Paloma García author non-byline.
Rubio Silvia Rodriguez author non-byline.
Exposito Marta Valero author non-byline.
Chatelus Emmanuel author non-byline.
Sibilia Jean author non-byline.
Gottenberg Jacques Eric author non-byline.
Chifflot Hélène author non-byline.
Litinsky Ira author non-byline.
Emery Paul author non-byline.
Buch Maya author non-byline.
Galdo Francesco Del author non-byline.
Venalis Algirdas author non-byline.
Butrimiene Irena author non-byline.
Venalis Paulius author non-byline.
Rugiene Rita author non-byline.
Karpec Diana author non-byline.
Lasky Joseph A author non-byline.
Cosentino Vanesa author non-byline.
Kerzberg Eduardo author non-byline.
Montoya Fabiana author non-byline.
Bianchi Washington author non-byline.
Carneiro Sueli author non-byline.
Maretti Giselle Baptista author non-byline.
Bianchi Dante Valdetaro author non-byline.
Limonta Massimiliano author non-byline.
Brucato Antonio Luca author non-byline.
Lupi Elide author non-byline.
Rosner Itzhak author non-byline.
Rozenbaum Michael author non-byline.
Slobodin Gleb author non-byline.
Boulman Nina author non-byline.
Rimar Doron author non-byline.
Couto Maura author non-byline.
Kahl Sarah author non-byline.
Chen Fei author non-byline.
McCloskey Deborah author non-byline.
Malveaux Halina author non-byline.
Spertini François author non-byline.
Ribi Camillo author non-byline.
Buss Guillaume author non-byline.
Martin Thierry author non-byline.
Guffroy Aurélien author non-byline.
Poindron Vincent author non-byline.
Chotchaeva Fatima author non-byline.
Mukhin Nikolay A author non-byline.
Moiseev Sergey author non-byline.
Herrick Ariane author non-byline.
… (more) - Abstract:
- Abstract : Objective: To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice. Methods: We performed a prospective study including patients with SSc from the European Scleroderma Trials and Research (EUSTAR) network treated with rituximab and matched with untreated patients with SSc. The main outcomes measures were adverse events, skin fibrosis improvement, lung fibrosis worsening and steroids use among propensity score-matched patients treated or not with rituximab. Results: 254 patients were treated with rituximab, in 58% for lung and in 32% for skin involvement. After a median follow-up of 2 years, about 70% of the patients had no side effect. Comparison of treated patients with 9575 propensity-score matched patients showed that patients treated with rituximab were more likely to have skin fibrosis improvement (22.7 vs 14.03 events per 100 person-years; OR: 2.79 [1.47–5.32]; p=0.002). Treated patients did not have significantly different rates of decrease in forced vital capacity (FVC)>10% (OR: 1.03 [0.55–1.94]; p=0.93) nor in carbon monoxide diffusing capacity (DLCO) decrease. Patients having received rituximab were more prone to stop or decrease steroids (OR: 2.34 [1.56–3.53], p<0.0001). Patients treated concomitantly with mycophenolate mofetil had a trend for better outcomes as compared with patients receiving rituximab alone (delta FVC: 5.22 [0.83–9.62]; p=0.019 as compared with controls vs 3 [0.66–5.35]; p=0.012). Conclusion:Abstract : Objective: To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice. Methods: We performed a prospective study including patients with SSc from the European Scleroderma Trials and Research (EUSTAR) network treated with rituximab and matched with untreated patients with SSc. The main outcomes measures were adverse events, skin fibrosis improvement, lung fibrosis worsening and steroids use among propensity score-matched patients treated or not with rituximab. Results: 254 patients were treated with rituximab, in 58% for lung and in 32% for skin involvement. After a median follow-up of 2 years, about 70% of the patients had no side effect. Comparison of treated patients with 9575 propensity-score matched patients showed that patients treated with rituximab were more likely to have skin fibrosis improvement (22.7 vs 14.03 events per 100 person-years; OR: 2.79 [1.47–5.32]; p=0.002). Treated patients did not have significantly different rates of decrease in forced vital capacity (FVC)>10% (OR: 1.03 [0.55–1.94]; p=0.93) nor in carbon monoxide diffusing capacity (DLCO) decrease. Patients having received rituximab were more prone to stop or decrease steroids (OR: 2.34 [1.56–3.53], p<0.0001). Patients treated concomitantly with mycophenolate mofetil had a trend for better outcomes as compared with patients receiving rituximab alone (delta FVC: 5.22 [0.83–9.62]; p=0.019 as compared with controls vs 3 [0.66–5.35]; p=0.012). Conclusion: Rituximab use was associated with a good safety profile in this large SSc-cohort. Significant change was observed on skin fibrosis, but not on lung. However, the limitation is the observational design. The potential stabilisation of lung fibrosis by rituximab has to be addressed by a randomised trial. … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 78:Issue 7(2019)
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 78:Issue 7(2019)
- Issue Display:
- Volume 78, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 78
- Issue:
- 7
- Issue Sort Value:
- 2019-0078-0007-0000
- Page Start:
- 979
- Page End:
- 987
- Publication Date:
- 2019-04-09
- Subjects:
- systemic sclerosis -- rituximab -- lung fibrosis -- skin fibrosis
Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2018-214816 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25273.xml